Bioventus/Seikagaku Extend SUPARTZ FX Distribution Agreement
Bioventus extended its agreement to exclusively distribute Seikagaku's SUPARTZ FX five-injection hyaluronic acid in the U.S. through May 2028....
Bioventus extended its agreement to exclusively distribute Seikagaku's SUPARTZ FX five-injection hyaluronic acid in the U.S. through May 2028....
Implanet entered into a U.S. distribution agreement with Aegis Spine, subsidiary of L&K Biomed, to complement Implanet's commercialization activity in...
Among its business updates, Amedica announced that the Taurus Pedicle Screw generated ~US $1.3MM in 2017 revenue and was employed...
The Arthroscopy Association of North America and VirtaMed signed an agreement to co-develop virtual reality arthroscopy simulation training....
Many AAOS 2018 exhibitors are addressing needs "beyond the device": systems to manage patient care, to deliver the implant to...
PALACOS® bone cement products are now available by direct sale in the U.S. through Heraeus Medical....
Ventris Medical has formed to market Cellesta placental allografts for surgical and non-surgical applications. ...
Histogenics entered into an agreement with MEDINET to develop and commercialize NeoCart® cartilage repair therapy in Japan....
Vericel initiated its Carticel/MACI distribution agreement with Innovative Cellular Therapeutics following a US $5.1MM upfront payment. ...
Zimmer Biomet has appointed Mr. Bryan C. Hanson as President, Chief Executive Officer and member of its Board of Directors, effective...
Login
Register for a free account
As a guest member you get access to more articles and videos every month.